Analysis of modified human papillomavirus type 16 L1 capsomeres: the ability to assemble into larger particles correlates with higher immunogenicity.
about
Structural Basis of Oligosaccharide Receptor Recognition by Human PapillomavirusCapsomer vaccines protect mice from vaginal challenge with human papillomavirusExpression of HPV-16 L1 capsomeres with glutathione-S-transferase as a fusion protein in tobacco plastids: an approach for a capsomere-based HPV vaccine.Vaccination with multimeric L2 fusion protein and L1 VLP or capsomeres to broaden protection against HPV infection.Multivalent human papillomavirus l1 DNA vaccination utilizing electroporation.Immunoprevention of human papillomavirus-associated malignanciesNon-carrier nanoparticles adjuvant modular protein vaccine in a particle-dependent manner.Multiscale simulation of microbe structure and dynamics.Plastid genetic engineering in SolanaceaeA Cell-Free Assembly System for Generating Infectious Human Papillomavirus 16 Capsids Implicates a Size Discrimination Mechanism for Preferential Viral Genome PackagingInfluence of oxidation and multimerization on the immunogenicity of a thioredoxin-l2 prophylactic papillomavirus vaccineChloroplast-derived vaccines against human diseases: achievements, challenges and scopes.Bioengineering virus-like particles as vaccines.HPV vaccines: Global perspectives.Crystal Structures of Two Immune Complexes Identify Determinants for Viral Infectivity and Type-Specific Neutralization of Human PapillomavirusImmunogenic assessment of plant-produced human papillomavirus type 16 L1/L2 chimaeras.Development of human papillomavirus chimaeric L1/L2 candidate vaccines.Explanations for the high potency of HPV prophylactic vaccines.Transplastomic expression of a modified human papillomavirus L1 protein leading to the assembly of capsomeres in tobacco: a step towards cost-effective second-generation vaccines.Emerging human papillomavirus vaccinesPlastid expression of a double-pentameric vaccine candidate containing human papillomavirus-16 L1 antigen fused with LTB as adjuvant: transplastomic plants show pleiotropic phenotypesN-terminal truncations on L1 proteins of human papillomaviruses promote their soluble expression in Escherichia coli and self-assembly in vitro
P2860
Q27666101-2D9C3A8F-566A-457C-A205-68E397055E0DQ28743261-588377BE-DAB7-43A8-A750-0595DE378CE3Q33723292-E1AF1B82-1E0E-4BE2-B047-28F9CD6CD521Q34054427-2ED7D053-9225-4C96-9BF8-6C040B3C8FF4Q34639978-BC43DF03-1904-4CF3-A175-006DC0118CDFQ35044376-CD679957-2999-4D9F-9867-7E4FD97027ABQ35165017-183819C2-B387-4E1E-9817-F9E597D16419Q36058098-7637904A-0A97-4D5F-87D4-04847985E94DQ36282010-8B214830-A6C2-4C6F-9113-18F3761A9BA7Q36434185-8003EA51-AFAF-43B4-AE28-E3F56B7E0D11Q36970255-805A5C63-93AA-4589-B520-BF790D1DA148Q37859086-07F27476-C741-4F0C-921D-38EBD7D0688CQ38172045-A88947D3-EDA4-47EB-B7E8-3F4FD91B09AFQ40265515-D3506E49-1AD9-4162-8DB1-3322C161B3C6Q41676237-60F87529-4097-4A23-84B7-9A787A758847Q42278396-38BC1E72-501C-4977-840B-9BE2507BBEA1Q43493362-38CF7C36-7EA5-45A9-93F7-3B53C838291BQ47554977-4429AABD-6DD3-4E8B-95BD-2537334BF32DQ54080674-85222E60-09FF-4A2B-BB14-4815633D307CQ56967486-092E2488-D046-4DD3-847F-C715435027ACQ57247534-F83272CB-D1F4-46CB-BA2E-B96959169F1FQ58696384-9D3DF893-D97A-47AA-A596-197D3B3DBB9D
P2860
Analysis of modified human papillomavirus type 16 L1 capsomeres: the ability to assemble into larger particles correlates with higher immunogenicity.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh-hant
name
Analysis of modified human pap ...... es with higher immunogenicity.
@en
Analysis of modified human pap ...... es with higher immunogenicity.
@nl
type
label
Analysis of modified human pap ...... es with higher immunogenicity.
@en
Analysis of modified human pap ...... es with higher immunogenicity.
@nl
prefLabel
Analysis of modified human pap ...... es with higher immunogenicity.
@en
Analysis of modified human pap ...... es with higher immunogenicity.
@nl
P2093
P2860
P356
P1433
P1476
Analysis of modified human pap ...... es with higher immunogenicity.
@en
P2093
Britta Gerlach
Corinna Klein
Ignacio G Bravo
Lutz Gissmann
Lysann Schädlich
Martin Müller
Norbert Mücke
Tilo Senger
P2860
P304
P356
10.1128/JVI.02588-08
P407
P577
2009-05-20T00:00:00Z